-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, LiKYNwOdvfZpbpF9uIL4sv3h4rFpFozhO6MOEK8ItVbo2y3+uxK5jYZk3iYlTXmi cUEP6gVCm0Zh0q/AIPIlrA== 0001181431-06-017457.txt : 20060310 0001181431-06-017457.hdr.sgml : 20060310 20060310194830 ACCESSION NUMBER: 0001181431-06-017457 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20060310 FILED AS OF DATE: 20060310 DATE AS OF CHANGE: 20060310 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HOLLIS EDEN PHARMACEUTICALS INC /DE/ CENTRAL INDEX KEY: 0000899394 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133697002 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4435 EASTGATE MALL STREET 2: SUITE 400 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-587-9333 MAIL ADDRESS: STREET 1: 4435 EASTGATE MALL STREET 2: SUITE 400 CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: INITIAL ACQUISITION CORP DATE OF NAME CHANGE: 19930329 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MCDONNELL BRENDAN CENTRAL INDEX KEY: 0001239651 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-24672 FILM NUMBER: 06680688 MAIL ADDRESS: STREET 1: C/O HOLLIS-EDEN PHARMACEUTICALS STREET 2: 4435 EASTGATE MALL STE.400 CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 rrd111016.xml OPTION SALE 03/10/2006 X0202 4 2006-03-10 0 0000899394 HOLLIS EDEN PHARMACEUTICALS INC /DE/ HEPH 0001239651 MCDONNELL BRENDAN 4435 EASTGATE MALL, SUITE 400 SAN DIEGO CA 92121 1 0 0 0 Common Stock 2006-03-10 4 M 0 5000 2.25 A 5000 D Common Stock 2006-03-10 4 S 0 5000 6.286 D 0 D Stock Option (Right to Buy) 2.25 2006-03-10 4 M 0 5000 0 D 2006-03-15 Common stock 5000 0 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2005 The option vested and became exercisable over a period of three years, and was fully exercisable beginning April 1, 1999 Eric J. Loumeau, Attorney-in-Fact 2006-03-10 -----END PRIVACY-ENHANCED MESSAGE-----